Search results for "Cardiovascular Disease"
Low-dose aspirin associated with 20% increase in risk of anemia among older adults
Analysis of a randomized trial of aspirin in healthy older patients found significantly increased risk of anemia, faster decline in hemoglobin concentrations, and greater decline in ferritin levels with aspirin versus placebo.
https://immattersacp.org/weekly/archives/2023/06/20/1.htm
20 Jun 2023
Discontinuing primary preventive aspirin didn't appear to increase mortality risk
Regular aspirin users who were switched to placebo in a randomized trial did not have increased risk of all-cause mortality or cardiovascular disease events compared with those who continued aspirin, but the findings of the post hoc analysis were inconclusive.
https://immattersacp.org/weekly/archives/2022/03/15/2.htm
15 Mar 2022
MKSAP Quiz: Follow-up for systemic lupus erythematosus
A 30-year-old woman is seen in follow-up. She was diagnosed with systemic lupus erythematosus 12 years ago. She was treated for lupus nephritis, which is now quiescent. What health risk assessment should be performed now?
https://immattersacp.org/weekly/archives/2022/04/05/3.htm
5 Apr 2022
USPSTF pulls back on recommendation of low-dose aspirin for primary prevention
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) now recommends against initiating low-dose aspirin for the primary prevention of cardiovascular disease in adults ages 60 years or older and says use should be an individual decision in patients ages 40 to 59 years.
https://immattersacp.org/weekly/archives/2021/10/19/5.htm
19 Oct 2021
Patients may respond differently to different hypertension drug classes
The authors of a randomized, double-blind, repeated crossover trial in Sweden estimated that personalized antihypertensive therapy could yield an average reduction in systolic blood pressure of 4.4 mm Hg compared to fixed-choice therapy.
https://immattersacp.org/weekly/archives/2023/04/18/1.htm
18 Apr 2023
Oldest patients least likely to receive statins despite potential benefits, study finds
Patients older than age 75 years were less likely to receive moderate- or high-intensity statins than those ages 65 to 75 years despite their higher incidence of atherosclerotic cardiovascular disease.
https://immattersacp.org/weekly/archives/2021/09/21/4.htm
21 Sep 2021
MKSAP Quiz: Treatment of elevated cholesterol levels
A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2021/12/14/3.htm
14 Dec 2021
Exercise may boost kidney function in sedentary older adults
Patients randomized to a physical activity and exercise intervention had statistically significantly lower decline in estimated glomerular filtration rate over two years versus those who received health education, a recent analysis found.
https://immattersacp.org/weekly/archives/2022/05/10/4.htm
10 May 2022
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023
Complementary, integrative health services increasing in VA system
Use of complementary and integrative therapies, such as chiropractic care, acupuncture, massage therapy, and yoga, increased 70% over a three-year period in the Veterans Affairs (VA) health system after their availability was expanded.
https://immattersacp.org/weekly/archives/2022/12/06/5.htm
6 Dec 2022